If you're on three to five chronic medications, switching every eligible prescription from brand-name to generic typically saves $1,500 to $3,500 per year in Canada and the US — without any clinical impact. Yet many patients keep paying brand-name prices, often because of myths about quality, marketing pressure, or simple inertia. This guide cuts through the noise: what bioequivalence really means, when to switch (almost always), when to be cautious (rarely), and how to start the conversation with your pharmacist or prescriber.
What "bioequivalence" actually means
For a generic to be approved by the FDA (US) or Health Canada, the manufacturer must prove bioequivalence — meaning the generic delivers the same active pharmaceutical ingredient (API) at the same rate and extent of absorption as the brand. Specifically, the generic's AUC (area under the concentration curve) and Cmax (peak concentration) must fall within 80-125% of the brand's measurements.
That sounds like wide variability, but the actual approved generics typically fall within 95-105% of brand performance — the 80-125% bracket is the regulatory ceiling, not the typical reality. Independent reviews of 2,070 bioequivalence studies (Davit et al., 2009) found average differences between generic and brand of just 4.35% for AUC.
What's identical, what differs
| Element | Generic vs Brand |
|---|---|
| Active ingredient (API) | ✓ Identical (chemically same molecule) |
| Dose | ✓ Identical (mg or units) |
| Route of administration | ✓ Identical (oral, IV, topical) |
| Bioavailability | ✓ Equivalent within ±5% on average |
| Inactive ingredients | ⚠ Can differ (binders, fillers, dyes) |
| Pill shape, color, imprint | ⚠ Often different |
| Manufacturing site | ⚠ Different facility, both FDA/HC inspected |
| Price | 💰 70-90% lower on average |
Top 10 medication classes by savings
| Class | Brand example | Generic | Savings |
|---|---|---|---|
| Statins (cholesterol) | Lipitor | atorvastatin | ~92% |
| PPIs (acid reflux) | Nexium | esomeprazole | ~88% |
| ARBs (blood pressure) | Diovan | valsartan | ~85% |
| SSRIs (depression) | Zoloft | sertraline | ~82% |
| Beta blockers | Toprol-XL | metoprolol succinate | ~80% |
| ACE inhibitors (BP) | Vasotec | enalapril | ~80% |
| Antibiotics | Cipro | ciprofloxacin | ~90% |
| Antihistamines | Allegra | fexofenadine | ~70% |
| Diabetes oral | Glucophage | metformin | ~85% |
| Birth control | various | various generics | ~60-75% |
The 5 categories where to slow down
Canada vs US specifics in 2026
Canada
Most provincial drug plans actively prefer generics. Quebec's RAMQ, Ontario's ODB, BC's PharmaCare — all reimburse generic at full eligible cost while requiring co-pay differential for brand. Most provinces cap generic prices at 18-25% of brand. Mandatory generic substitution unless prescriber explicitly writes "no substitution" with clinical reason.
United States
More variability — same generic can vary 50%+ in price between Costco, Walmart, CVS, and Walgreens for the same town. Always check 2-3 pharmacies for the same script. GoodRx and similar tools compare generic prices across pharmacies in real time. Mail-order pharmacy via insurance often offers lower per-pill cost on chronic generics (90-day supply).
How to start the conversation
With your pharmacist (easiest, no appointment needed):
"I'd like to review my prescriptions to see where switching to generic could save me money. Can you tell me which of my current medications already have generics, and what the price difference is?"
With your prescriber (for narrow-therapeutic-index drugs or specific concerns):
"I'm trying to reduce my medication costs. For [specific drug], is the generic version clinically equivalent for my situation, or do you recommend staying on brand?"
Most physicians and pharmacists welcome these conversations — they're aware of cost-related medication non-adherence (patients skipping doses to stretch supply) and prefer you afford a generic than skip a brand.
Three myths worth addressing
Myth 1: Generics are made in inferior facilities. All FDA-approved and Health Canada-approved generics are made in inspected facilities meeting the same Good Manufacturing Practice (GMP) standards as brand manufacturers. Many generics are made in the SAME facility that manufactures the brand (the brand company often produces the generic version under contract).
Myth 2: Generics are made in China. Mixed reality. Many APIs come from India and China, but final-dose manufacturing happens worldwide including the US, Canada, Israel, and EU. The same is true of brand-name drugs — supply chains are global. Quality is regulated by inspection, not country of origin.
Myth 3: My doctor recommends brand because brand is better. Sometimes physicians prescribe brand by habit, sample availability, or marketing exposure rather than clinical superiority. Ask directly: "Is there a clinical reason for brand-name on this prescription?" If the answer is unclear, the generic is virtually always the rational choice.